Antipsychotics and Cardiac Side Effects

Christoffer Polcwiartek, Benjamin Sneider, Claus Graff, David Taylor, Jonathan Meyer, Jørgen K. Kanters, Jimmi Nielsen, The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach Psychopharmacology. ,vol. 232, pp. 3297- 3308 ,(2015) , 10.1007/S00213-015-4024-9

Ruth Brauer, Ian Douglas, Liam Smeeth, The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. British Journal of Clinical Pharmacology. ,vol. 72, pp. 871- 878 ,(2011) , 10.1111/J.1365-2125.2011.04043.X

Jimmi Nielsen, QTc prolongation and clozapine: fact or artefact? Australian and New Zealand Journal of Psychiatry. ,vol. 46, pp. 793- 794 ,(2012) , 10.1177/0004867412444625

Hee‐Doo Yoo, Sang‐No Lee, Hyun‐Ah Kang, Hea‐Young Cho, Il‐Kwon Lee, Yong‐Bok Lee, Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10. British Journal of Pharmacology. ,vol. 164, pp. 433- 443 ,(2011) , 10.1111/J.1476-5381.2011.01385.X

James J. Gugger, Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management. CNS Drugs. ,vol. 25, pp. 659- 671 ,(2011) , 10.2165/11591710-000000000-00000

Brian C. Lund, Paul J. Perry, John M. Brooks, Stephan Arndt, Clozapine Use in Patients With Schizophrenia and the Risk of Diabetes, Hyperlipidemia, and Hypertension Archives of General Psychiatry. ,vol. 58, pp. 1172- 1176 ,(2001) , 10.1001/ARCHPSYC.58.12.1172

Christoph U. Correll, Todd Lencz, Anil K. Malhotra, Antipsychotic drugs and obesity Trends in Molecular Medicine. ,vol. 17, pp. 97- 107 ,(2011) , 10.1016/J.MOLMED.2010.10.010

Roberto Coccurello, Anna Moles, Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. Pharmacology & Therapeutics. ,vol. 127, pp. 210- 251 ,(2010) , 10.1016/J.PHARMTHERA.2010.04.008

Viktoria Simon, Ruud van Winkel, Marc De Hert, Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. The Journal of Clinical Psychiatry. ,vol. 70, pp. 1041- 1050 ,(2009) , 10.4088/JCP.08R04392

Jimmi Nielsen, Christoph U. Correll, Peter Manu, John M. Kane, Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? The Journal of Clinical Psychiatry. ,vol. 74, pp. 603- 613 ,(2013) , 10.4088/JCP.12R08064